Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Effect Of Oxygen-Supply On The 6-Minute-Walking-Distance in Patients With Chronic Obstructive Pulmonary Disease (COPD) GOLD Stage III/IV Before And After A Multimodal Rehabilitation
The aim of this study is to investigate the six-minute-walking-distance of COPD-patients with breathing oxygen in comparison to breathing normal air. Patients, who increase their walking-distance about more than 15% or 35m only because of breathing oxygen, are so-called "Oxygen Responders." The study is aimed to find attributes of Oxygen Responder and to investigate, if a patient can change the "respond" with higher performance and endurance.
Status | Completed |
Enrollment | 127 |
Est. completion date | August 2009 |
Est. primary completion date | June 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Chronic obstructive pulmonary disease III/IV Exclusion Criteria: - Severe exacerbations in the last 4 weeks prior to begin of study (definition of exacerbation: symptoms on more than 3 days with a relevant change in drug therapy (cortisone, antibiotics)) - Severe exacerbation during rehabilitation - Cardiac insufficiency |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Screening
Country | Name | City | State |
---|---|---|---|
Germany | Klinikum Berchtesgadener Land, Schön Kliniken | Schönau am Königssee |
Lead Sponsor | Collaborator |
---|---|
Klinikum Berchtesgadener Land der Schön-Kliniken | ROX Medical, Inc. |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Oxygen Response | Change in oxygen response (6-minute-walking distance on oxygen minus 6-minute-walking distance on medical air) from baseline to 3 weeks | day 1 and day 2; day 21 and day 22 | Yes |
Secondary | Oxygen Partial Pressure (paO2) | change in paO2 from minute 0 to minute 6 in 6-minute-walking test on oxygen/ medical air | day 1: minute "0" and "6" | No |
Secondary | Diffusion Capacity | change in diffusion capacity from baseline to 3 weeks | day 1 and 21 | No |
Secondary | Lung Function | change in lung function from baseline to 3 weeks | day 1 and 21 | No |
Secondary | BORG-Score | change of BORG-Score from pre to post 6 minute-walking test (minute 0 and 6)on oxygen/ medical air | day 1: minute 0 and minute 6 | No |
Secondary | Oxygen Saturation | Change of oxygen saturation from minute 0 to 6 in 6Minute-walking test on oxygen/ medical air | day 1: minute 0 and 6 | No |
Secondary | Oxygen Partial Pressure (paO2) | change in paO2 from minute 0 to minute 6 in 6-minute-walking test on oxygen/ medical air | day 21: minute 0 and minute 6 | No |
Secondary | BORG-Score | change of BORG-Score from pre to post 6 minute-walking test (minute 0 and 6)on oxygen/ medical air | day 2: minute 0 and minute 6 | No |
Secondary | BORG-Score | change of BORG-Score from pre to post 6 minute-walking test (minute 0 and 6)on oxygen/ medical air | day 22: minute 0 and minute 6 | No |
Secondary | BORG-Score | change of BORG-Score from pre to post 6 minute-walking test (minute 0 and 6)on oxygen/ medical air | day 21: minute 0 and minute 6 | No |
Secondary | Oxygen Partial Pressure (paO2) | change in paO2 from minute 0 to minute 6 in 6-minute-walking test on oxygen/ medical air | day 20: minute 0 and minute 6 | No |
Secondary | Oxygen Partial Pressure (paO2) | change in paO2 from minute 0 to minute 6 in 6-minute-walking test on oxygen/ medical air | day 2: minute "0" and "6" | No |
Secondary | Oxygen Saturation | Change of oxygen saturation from minute 0 to 6 in 6Minute-walking test on oxygen/ medical air | day 2: minute 0 and 6 | No |
Secondary | Oxygen Saturation | Change of oxygen saturation from minute 0 to 6 in 6Minute-walking test on oxygen/ medical air | day 21: minute 0 and 6 | No |
Secondary | Oxygen Saturation | Change of oxygen saturation from minute 0 to 6 in 6Minute-walking test on oxygen/ medical air | day 22: minute 0 and 6 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|